Stem cell-based treatments against stroke: Observations from human proof-of-concept studies and considerations regarding clinical applicability

Frontiers in Cellular Neuroscience

Volumn 8, Issue October, 2014, Pages

  Doeppner, Thorsten R ^a   Hermann, Dirk M ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Mesenchymal stem cells; Neural progenitor cells; Stem cells; Stroke; Trials

Indexed keywords

5' NUCLEOTIDASE; ENDOGLIN; TECHNETIUM 99M; THY 1 ANTIGEN;

BLOOD CLOT LYSIS; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL HOMING; DIFFUSION WEIGHTED IMAGING; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEURAL STEM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; REVIEW; SCORING SYSTEM; STEM CELL TRANSPLANTATION; SUBVENTRICULAR ZONE;

EID: 84908373496     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00357     Document Type: Review

References (68)

1. Aggarwal, S., and Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822. doi: 10.1182/blood-2004-04-1559
2. Alvarez-Buylla, A., and Garcia-Verdugo, J. M. (2002). Neurogenesis in adult sub-ventricular zone. J. Neurosci. 22, 629-634
3. Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., and Lindvall, O. (2002). Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8, 963-970. doi: 10.1038/nm747
4. Bacigaluppi, M., Pluchino, S., Martino, G., Kilic, E., and Hermann, D. M. (2008). Neural stem/precursor cells for the treatment of ischemic stroke. J. Neurol. Sci. 265, 73-77. doi: 10.1016/j.jns.2007.06.012
5. Bacigaluppi, M., Pluchino, S., Peruzzotti Jametti, L., Kilic, E., Kilic, U., Salani, G., et al. (2009). Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 132, 2239-2251. doi: 10.1093/brain/awp174
6. Banerjee, S., Williamson, D. A., Habib, N., and Chataway, J. (2012). The potential benefit of stem cell therapy after stroke: an update. Vasc. Health Risk Manag. 8, 569-580. doi: 10.2147/VHRM.s25745
7. Bang, O. Y., Lee, J. S., Lee, P. H., and Lee, G. (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57, 874-882. doi: 10. 1002/ana.20501
8. Barbosa da Fonseca, L. M., Gutfilen, B., Rosado de Castro, P. H., Battistella, V., Goldenberg, R. C., Kasai-Brunswick, T., et al. (2010). Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp. Neurol. 221, 122-128. doi: 10.1016/j.expneurol.2009. 10.010
9. Battistella, V., de Freitas, G. R., da Fonseca, L. M., Mercante, D., Gutfilen, B., Goldenberg, R. C., etal. (2011). Safetyofautologousbone marrowmononuclear cell transplantation in patients with nonacute ischemic stroke. Regen. Med. 6, 45-52. doi: 10.2217/rme.10.97
10. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., et al. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214-2219. doi: 10.1182/blood-2004-07-2921
11. Bhasin, A., Srivastava, M. V., Kumaran, S. S., Mohanty, S., Bhatia, R., Bose, S., et al. (2011) . Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc. Dis. Extra 1, 93-104. doi: 10.1159/000333381
12. Bhasin, A., Srivastava, M. V., Mohanty, S., Bhatia, R., Kumaran, S. S., and Bose, S. . Stem cell therapy: a clinical trial of stroke. Clin. Neurol. Neurosurg. 115, 1003-1008. doi: 10.1016/j.clineuro.2012.10.015
13. Bliss, T. M., Andres, R. H., and Steinberg, G. K. (2010). Optimizing the success of cell transplantation therapy for stroke. Neurobiol. Dis. 37, 275-283. doi: 10. 1016/j.nbd.2009.10.003
14. Bliss, T., Guzman, R., Daadi, M., and Steinberg, G. K. (2007). Cell transplantation therapy for stroke. Stroke 38, 817-826. doi: 10.1161/01.str.0000247888. 25985.62
15. Blum, B., and Benvenisty, N. (2008). The tumorigenicityofhuman embryonic stem cells. Adv. Cancer Res. 100, 133-158. doi: 10.1016/S0065-230X(08)00005-5
16. Blum, B., and Benvenisty, N. (2009). The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8, 3822-3830. doi: 10.4161/cc.8.23. 10067
17. Braun, S. M., and Jessberger, S. (2014). Adult neurogenesis: mechanisms and functional significance. Development 141, 1983-1986. doi: 10.1242/dev.104596
18. Caplan, A. I. (2009). Why are MSCs therapeutic? New data: new insight. J. Pathol.217, 318-324. doi: 10.1002/path.2469
19. Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., et al. (2001). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011. doi: 10.1161/01.str.32.4.1005
20. Chen, J., Ye, X., Yan, T., Zhang, C., Yang, X. P., Cui, X., et al. (2011). Adverse effects ofbone marrowstromal cell treatment ofstroke in diabeticrats. Stroke 42, 3551-3558. doi: 10.1161/STR0KEAHA.111.627174
21. Chen, J., Zhang, Z. G., Li, Y., Wang, L., Xu, Y. X., Gautam, S. C., et al. (2003). Intravenous administration ofhuman bone marrowstromal cells induces angio-genesis in the ischemic boundaryzone after stroke in rats. Circ. Res. 92, 692-699. doi: 10.1161/01.res.0000063425.51108.8d
22. Delavaran, H., Sjunnesson, H., Arvidsson, A., Lindvall, O., Norrving, B., van Westen, D., et al. (2013). Proximity of brain infarcts to regions of endogenous neurogenesis and involvement of striatum in ischaemic stroke. Eur. J. Neurol. 20, 473-479. doi: 10.1111/j.1468-1331.2012.03877.x
23. Doeppner, T. R., Dietz, G. P., El Aanbouri, M., Gerber, J., Witte, O. W., Bahr, M., et al. (2009). TAT-Bcl-x(L) improves survival of neuronal precursor cells in the lesioned striatum after focal cerebral ischemia. Neurobiol. Dis. 34, 87-94. doi: 10. 1016/j.nbd.2008.12.013
24. Doeppner, T. R., El Aanbouri, M., Dietz, G. P., Weise, J., Schwarting, S., and Bähr, M. (2010). Transplantation of TAT-Bcl-xL-transduced neural precursor cells: long-term neuroprotection after stroke. Neurobiol. Dis. 40, 265-276. doi: 10. 1016/j.nbd.2010.05.033
25. Doeppner, T. R., Ewert, T. A., Tönges, L., Herz, J., Zechariah, A., Elali, A., et al. (2012). Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation. Stem Cells 30, 1297-1310. doi: 10.1002/stem.1098
26. Doeppner, T. R., and Hermann, D. M. (2010). Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities. Stem Cells Cloning 3, 157-163. doi: 10.2147/SCCAA.s7820
27. Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M., and Alvarez-Buylla, A. (1999). Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97, 703-716. doi: 10.1016/s0092-8674(00)80783-7
28. Doetsch, F., García-Verdugo, J. M., and Alvarez-Buylla, A. (1997). Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J. Neurosci. 17, 5046-5061
29. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international societyfor cellular therapyposition statement. Cytother-apy 8, 315-317. doi: 10.1080/14653240600855905
30. Haas, S., Weidner, N., and Winkler, J. (2005). Adult stem cell therapy in stroke. Curr. Opin. Neurol. 18, 59-64. doi: 10.1097/00019052-200502000-00012
31. Hermann, D. M., and Chopp, M. (2012). Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 11, 369-380. doi: 10.1016/S1474-4422(12) 70039-X
32. Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., et al. (2011). Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134, 1790-1807. doi: 10.1093/brain/awr063
33. Jessberger, S., and Gage, F. H. (2014).Adult neurogenesis: bridging the gap between mice and humans. Trends Cell Biol. 24, 558-563. doi: 10.1016/j.tcb.2014.07.003
34. Kondziolka, D., Steinberg, G. K., Wechsler, L., Meltzer, C. C., Elder, E., Gebel, J., et al. (2005). Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J. Neurosurg. 103, 38-45. doi: 10.3171/jns.2005.103.1. 0038
35. Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thulborn, K. R., Gebel, J., et al. (2000). Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55, 565-569. doi: 10.1212/wnl.55.4.565
36. Kranz, A., Wagner, D. C., Kamprad, M., Scholz, M., Schmidt, U. R., Nitzsche, F., et al. (2010). Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res. 1315, 128-136. doi: 10.1016/j. brainres.2009.12.001
37. Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Ishii, K., Kobune, M., et al. (2005). Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther. 11, 96-104. doi: 10.1016/j.ymthe.2004.09.020
38. Lalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C., et al. (2012). Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 7:e47559. doi: 10.1371/journal.pone.0047559
39. Lazennec, G., and Jorgensen, C. (2008). Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem cells 26,1387-1394. doi: 10.1634/stemcells. 2007-1006
40. Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., Bang, O. Y., et al. (2010). A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099-1106. doi: 10.1002/stem.430
41. Leong, W. K., Henshall, T. L., Arthur, A., Kremer, K. L., Lewis, M. D., Helps, S. C., et al. (2012). Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl. Med. 1, 177-187. doi: 10.5966/sctm.2011-0039
42. Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., et al. (2002). Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59, 514-523. doi: 10.1212/wnl.59.4.514
43. Liu, J., Solway, K., Messing, R. O., and Sharp, F. R. (1998). Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18, 7768-7778
44. Mitkari, B., Nitzsche, F., Kerkela, E., Kuptsova, K., Huttunen, J., Nystedt, J., et al. (2014). Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery. Behav. Brain Res. 259, 50-59. doi: 10.1016/j.bbr.2013.10.030
45. Moniche, F., Gonzalez, A., Gonzalez-Marcos, J. R., Carmona, M., Piñero, P., Espi-gado, I., et al. (2012). Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 43, 2242-2244. doi: 10.1161/STR0KEAHA. 112.659409
46. Mora-Lee, S., Sirerol-Piquer, M. S., Gutiérrez-Pérez, M., Gomez-Pinedo, U., Roo-brouck, V. D., López, T., et al. (2012). Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One 7:e43683. doi: 10.1371/journal. pone.0043683
47. Onda, T., Honmou, O., Harada, K., Houkin, K., Hamada, H., and Kocsis, J. D. (2008). Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J. Cereb. Blood FlowMetab. 28, 329-340. doi: 10.1038/sj.jcbfm.9600527
48. Parent, J. M. (2003). Injury-induced neurogenesis in the adult mammalian brain. Neuroscientist 9,261-272. doi: 10.1177/1073858403252680
49. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. doi: 10.1126/science.284.5411.143
50. Rabinovich, S. S., Seledtsov, V. I., Banul, N. V., Poveshchenko, O. V., Senyukov, V. V., Astrakov, S. V., et al. (2005). Cell therapy of brain stroke. Bull. Exp. Biol. Med. 139, 126-128
51. Savitz, S. I., Dinsmore, J., Wu, J., Henderson, G. V., Stieg, P., and Caplan, L. R. (2005). Neurotransplantation offetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc. Dis. 20, 101-107. doi: 10.1159/000086518
52. Savitz, S. I., Misra, V., Kasam, M., Juneja, H., Cox, C. S. Jr., Alderman, S., et al. (2011). Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann. Neurol. 70, 59-69. doi: 10.1002/ana.22458
53. Sawada, M., Matsumoto, M., and Sawamoto, K. (2014). Vascular regulation of adult neurogenesis under physiological and pathological conditions. Front. Neurosci. 8:53. doi: 10.3389/fnins.2014.00053
54. Schwarting, S., Litwak, S., Hao, W., Bähr, M., Weise, J., and Neumann, H. (2008). Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39, 2867-2875. doi: 10.1161/strokeaha.108.513978
55. Sheikh, A. M., Nagai, A., Wakabayashi, K., Narantuya, D., Kobayashi, S., Yamaguchi, S., et al. (2011). Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5, Neurobiol. Dis. 41, 717-724. doi: 10.1016/j.nbd.2010.12.009
56. Shen, L. H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., et al. (2007). Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. BloodFlowMetab. 27, 6-13. doi: 10.1038/sj.jcbfm.9600311
57. Silva-Vargas, V., Crouch, E. E., and Doetsch, F. (2013). Adult neural stem cells and their niche: a dynamic duo during homeostasis, regeneration and aging. Curr. Opin. Neurobiol. 23, 935-942. doi: 10.1016/j.conb.2013.09.004
58. Spees, J. L., Gregory, C. A., Singh, H., Tucker, H. A., Peister, A., Lynch, P. J., et al. (2004). Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol. Ther. 9, 747-756. doi: 10. 1016/j.ymthe.2004.02.012
59. Steiner, B., Roch, M., Holtkamp, N., and Kurtz, A. (2012). Systemically administered human bone marrow-derived mesenchymal stem home into peripheral organs but do not induce neuroprotective effects in the MCAo-mouse model for cerebral ischemia. Neurosci. Lett. 513, 25-30. doi: 10.1016/j.neulet.2012. 01.078
60. Suárez-Monteagudo, C., Hernández-Ramirez, P., Alvarez-González, L., García-Maeso, I., de la Cuétara-Bernal, K., Castillo-Díaz, L., et al. (2009). Autologous bone marrow stem cell neurotransplantation in stroke patients. Restor. Neurol. Neurosci. 27, 151-161. doi: 10.3233/RNN-2009-0483
61. Taupin, P., and Gage, F. H. (2002). Adult neurogenesis and neural stem cells of the central nervous system in mammals. J. Neurosci. Res. 69, 745-749. doi: 10. 1002/jnr.10378
62. Tonchev, A. B., Yamashima, T., Zhao, L., and Okano, H. (2003). Differential proliferative response in the postischemic hippocampus, temporal cortex and olfactory bulb of young adult macaque monkeys. Glia 42, 209-224. doi: 10. 1002/glia.10209
63. Ukai, R., Honmou, O., Harada, K., Houkin, K., Hamada, H., and Kocsis, J. D. (2007). Mesenchymal stem cells derived from peripheral blood protects against ischemia. J. Neurotrauma 24, 508-520. doi: 10.1089/neu.2006.0161
64. Yamashita, T., Ninomiya, M., Hernández Acosta, P., García-Verdugo, J. M., Suna-bori, T., Sakaguchi, M., et al. (2006). Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J. Neurosci. 26, 6627-6636. doi: 10.1523/jneurosci.0149-06.2006
65. Yang, B., Migliati, E., Parsha, K., Schaar, K., Xi, X., Aronowski, J., et al. (2013). Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke 44, 3463-3472. doi: 10.1161/strokeaha.111.000821
66. Yoo, S. W., Kim, S. S., Lee, S. Y., Lee, H. S., Kim, H. S., Lee, Y. D., et al. (2008). Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp. Mol. Med. 40, 387-397. doi: 10.3858/emm.2008.40.4.387
67. Zhang, J., and Chopp, M. (2013). Cell-based therapy for ischemic stroke. Expert Opin. Biol. Ther. 13, 1229-1240. doi: 10.1517/14712598.2013.804507
68. Zheng, W., Honmou, O., Miyata, K., Harada, K., Suzuki, J., Liu, H., et al. (2010). Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res. 1310, 8-16. doi: 10.1016/j. brainres.2009.11.012